Stock Events

Stock Events

Pulse Biosciences 

€46.20
16
-€1.80-3.75%Friday 16:30

Statistics

Day High
48.8
Day Low
47.4
52W High
51
52W Low
39
Volume
101
Avg. Volume
-
Mkt Cap
3.3B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 5Expected
Q2 2026
Q3 2026
-0.28
-0.26
-0.24
-0.22
Expected EPS
-0.27565927
Actual EPS
-0.21600375385999998

Financials

-21,173.34%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
298,272.26Revenue
-63.15MNet Income

Analyst Ratings

$51.75Average Price Target
The highest estimate is ⁦56.15⁩.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6L8.XETRA. It's not an investment recommendation.
Schwab US Dividend Equity
3
SCHD
Coca-Cola
3
KO
Johnson & Johnson
3
JNJ
AT&T
3
T

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation offers a wide range of medical devices that compete in the cardiovascular and neuromodulation markets, overlapping with Pulse Biosciences' therapeutic areas.
Medtronic
MDT
Mkt Cap123.49B
Medtronic is a global leader in medical technology, services, and solutions, competing across several of Pulse Biosciences' key areas, including cardiac and vascular therapies.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical, known for its da Vinci surgical systems, competes with Pulse Biosciences in the field of minimally invasive surgery, albeit through different technological approaches.
Stryker
SYK
Mkt Cap111.95B
Stryker is a medical technologies firm that competes with Pulse Biosciences in the development of surgical and neurotechnology products.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, offering products that can be seen as alternatives to Pulse Biosciences' treatments.
Edwards Lifesciences
EW
Mkt Cap53.03B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing with Pulse Biosciences in the broader field of medical devices for cardiovascular health.
Baxter International
BAX
Mkt Cap11.9B
Baxter International Inc. provides a broad portfolio of renal and hospital products, including bio-surgery products that compete with Pulse Biosciences' offerings in the surgical market.

About

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Show More
CEO
Paul Arthur LaViolette
Employees
116
Country
United States
ISIN
US74587B1017
WKN
000A2AMY9

Listings

STU
DE
6L8.STU
F
DE
6L8.F
MU
DE
6L8.MU
XNAS
US
PLSE

0 Comments

Share your thoughts

FAQs

What is Pulse Biosciences stock price today?▼
The current price of 6L8.XETRA is €46.20 EUR — it has decreased by -3.75% in the past 24 hours. Watch Pulse Biosciences stock price performance more closely on the chart.
What is Pulse Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange Pulse Biosciences stocks are traded under the ticker 6L8.XETRA.
What is Pulse Biosciences market cap?▼
Today Pulse Biosciences has the market capitalization of 3.3B
When is the next Pulse Biosciences earnings date?▼
Pulse Biosciences is going to release the next earnings report on April 1, 2027.
What were Pulse Biosciences earnings last quarter?▼
6L8.XETRA earnings for the last quarter are -0.22 EUR per share, whereas the estimation was -0.28 EUR resulting in a +21.64% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Pulse Biosciences revenue for the last year?▼
Pulse Biosciences revenue for the last year amounts to 298,272.26 EUR.
What is Pulse Biosciences net income for the last year?▼
6L8.XETRA net income for the last year is -63.15M EUR.
How many employees does Pulse Biosciences have?▼
As of November 8, 2026, the company has 116 employees.
In which sector is Pulse Biosciences located?▼
Pulse Biosciences operates in the Health & Wellness sector.
When did Pulse Biosciences complete a stock split?▼
Pulse Biosciences has not had any recent stock splits.
Where is Pulse Biosciences headquartered?▼
Pulse Biosciences is headquartered in HAYWARD, United States.